In a recent turn of events, the Apple Watch ban has hit a temporary roadblock. A federal appeals court has issued a ruling putting a pause on the import ban of Apple's most cutting-edge watches, including the Series 9 and the Ultra 2, which were slated to go into effect today. The ban stems from an ongoing patent dispute concerning the blood oxygen monitoring technology featured in these advanced Apple Watch models.
The dispute revolves around allegations of patent infringement put forth by California-based company Massimo. The International Trade Commission had previously ruled in October that the blood oxygen monitoring technology used in the aforementioned Apple Watch models indeed infringed upon Massimo's patent. Consequently, Apple was prohibited from importing these high-end models.
